These samples consisted of invasive ductal adenocarcinoma with HER2 overexpression (3+) and ductal adenocarcinoma with slightly elevated HER2 expression (1+), benign breast epithelia (0) adjacent to a 3+ tumour region and normal breast epithelia (0). The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.